Senior(SZ:300568)2025-04-28 13:50Financial Performance - The company's revenue for Q1 2025 was ¥889,326,970.34, representing a 24.44% increase compared to ¥714,664,270.19 in the same period last year[5]. - Net profit attributable to shareholders decreased by 56.39% to ¥46,708,487.39 from ¥107,110,892.18 year-on-year[5]. - The total operating revenue for the current period reached ¥889,326,970.34, an increase of 24.5% compared to ¥714,664,270.19 in the previous period[20]. - The company reported a net profit of ¥32,135,439.85 for the current period, compared to a net profit of ¥111,360,757.93 in the previous period, indicating a significant decline[20]. - The net profit for the current period is CNY 50,392,675.74, a decrease from CNY 105,999,165.84 in the previous period, representing a decline of approximately 52.5%[21]. - The total comprehensive income for the current period is CNY 188,508,964.88, compared to CNY 129,931,242.94 in the previous period, indicating an increase of about 45%[22]. - The total operating profit for the current period is CNY 47,223,279.22, significantly lower than CNY 124,698,906.71 in the previous period, a decline of approximately 62.3%[21]. Cash Flow - The net cash flow from operating activities increased by 52.91% to ¥199,803,696.48, up from ¥130,667,714.74 in the previous year[5]. - Cash flow from operating activities generated a net amount of CNY 199,803,696.48, up from CNY 130,667,714.74 in the previous period, reflecting an increase of approximately 52.9%[23]. - Cash flow from investing activities resulted in a net outflow of CNY 1,432,646,987.23, worsening from a net outflow of CNY 1,304,425,881.05 in the previous period[24]. - Cash flow from financing activities yielded a net inflow of CNY 830,295,451.44, down from CNY 1,282,031,055.59 in the previous period, indicating a decrease of about 35.1%[24]. Assets and Liabilities - The total assets at the end of the reporting period were ¥23,659,667,048.17, a 2.22% increase from ¥23,145,534,457.87 at the end of the previous year[5]. - The company's total liabilities rose to ¥13,588,652,259.56, compared to ¥13,174,412,900.75, marking an increase of 3.1%[19]. - The equity attributable to shareholders increased to ¥9,895,346,755.94 from ¥9,799,137,712.80, a growth of 1.0%[19]. Shareholder Information - The company’s major shareholder, Chen Xiufeng, holds 12.70% of the shares, totaling 170,489,491 shares[11]. - The second-largest shareholder, the National Social Security Fund Six, holds 2.68% of the shares, totaling 35,950,322 shares[11]. - The company has a total of 129,026,758 restricted shares at the end of the period, with 100,258 shares released during the current period[13]. - The company has not disclosed any related party relationships among the top shareholders[11]. Stock Repurchase and Future Plans - The company has approved a share repurchase plan with a total amount not less than 50 million RMB and not exceeding 100 million RMB, with a maximum repurchase price of 14.60 RMB per share[15]. - As of March 6, 2025, the company has repurchased a total of 8,580,200 shares, accounting for 0.64% of the total share capital, with an average transaction price of 11.65 RMB per share[16]. - The company’s stock repurchase aligns with its financial status and future profitability considerations[15]. - The company plans to focus on expanding its market presence and investing in new technologies to drive future growth[20]. Financial Ratios and Expenses - The company's basic and diluted earnings per share both decreased by 62.50% to ¥0.03 from ¥0.08 year-on-year[5]. - The weighted average return on equity fell to 0.35%, down from 1.09% in the same period last year, a decrease of 0.74%[5]. - The company reported a significant increase in financial expenses, which rose by 699.17% to ¥49,201,407.90 due to increased interest expenses[8]. - Total operating costs amounted to ¥857,191,530.49, up 42.2% from ¥603,303,512.26 in the prior period[20]. - The gross profit margin decreased, with operating costs representing 74.5% of total revenue compared to 64.1% in the previous period[20]. - Research and development expenses were ¥56,097,981.68, slightly increasing from ¥55,488,111.96 year-over-year[20].